Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1980 1
1981 1
1986 1
1998 1
2001 1
2002 1
2004 1
2005 1
2007 1
2008 1
2011 2
2013 2
2014 5
2015 1
2016 2
2017 3
2018 5
2019 5
2020 3
2021 5
2022 5
2023 3
2024 6
2025 3
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Dosimetry of 177Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: Correlations Between Pretherapeutic Imaging and Whole-Body Tumor Dosimetry with Treatment Outcomes.
Violet J, Jackson P, Ferdinandus J, Sandhu S, Akhurst T, Iravani A, Kong G, Kumar AR, Thang SP, Eu P, Scalzo M, Murphy D, Williams S, Hicks RJ, Hofman MS. Violet J, et al. J Nucl Med. 2019 Apr;60(4):517-523. doi: 10.2967/jnumed.118.219352. Epub 2018 Oct 5. J Nucl Med. 2019. PMID: 30291192 Free article. Clinical Trial.
After therapy, patients underwent quantitative SPECT/CT at 4, 24, and 96 h. Pharmacokinetic uptake and clearance at a voxel level were calculated and translated into absorbed dose using voxel S values. ...
After therapy, patients underwent quantitative SPECT/CT at 4, 24, and 96 h. Pharmacokinetic uptake and clearance at a voxel level wer …
Lutetium-177-PSMA-617 or cabazitaxel in metastatic prostate cancer: circulating tumor DNA analysis of the randomized phase 2 TheraP trial.
Kwan EM, Ng SWS, Tolmeijer SH, Emmett L, Sandhu S, Buteau JP, Iravani A, Joshua AM, Francis RJ, Subhash V, Lee ST, Scott AM, Martin AJ, Stockler MR, Donnellan G, Annala M, Herberts C, Davis ID, Hofman MS, Azad AA, Wyatt AW; TheraP Investigators and the ANZUP Cancer Trials Group. Kwan EM, et al. Nat Med. 2025 Aug;31(8):2722-2736. doi: 10.1038/s41591-025-03704-9. Epub 2025 May 27. Nat Med. 2025. PMID: 40425844 Clinical Trial.
SPECT/CT in Early Response Assessment of Patients with Metastatic Castration-Resistant Prostate Cancer Receiving 177Lu-PSMA-617.
Demirci RA, Gulati R, Hawley JE, Yezefski T, Haffner MC, Cheng HH, Montgomery RB, Schweizer MT, Yu EY, Nelson PS, Chen DL, Iravani A. Demirci RA, et al. J Nucl Med. 2024 Dec 3;65(12):1945-1951. doi: 10.2967/jnumed.124.267665. J Nucl Med. 2024. PMID: 39510589 Free PMC article.
Methods: Between June and December 2022, consecutive patients with mCRPC who received at least 2 administrations of LuPSMA with SPECT/CT 24 h after treatment were retrospectively reviewed. We evaluated associations between TTVs and the appearance of NLs at cycles 2 and 3 w …
Methods: Between June and December 2022, consecutive patients with mCRPC who received at least 2 administrations of LuPSMA with SPECT/CT 24 …
Association of Prior PARP Inhibitor Exposure with Clinical Outcomes after 177Lu-PSMA-617 in Men with Castration-resistant Prostate Cancer and Mutations in DNA Homologous Recombination Repair Genes.
Raychaudhuri R, Tuchayi AM, Low SK, Arafa AT, Graham LS, Gulati R, Pritchard CC, Montgomery RB, Haffner MC, Nelson PS, Yu EY, Hawley JE, Cheng HH, Mo G, Chen DL, Antonarakis ES, Kilari D, Hope TA, Iravani A, Schweizer MT. Raychaudhuri R, et al. Eur Urol Oncol. 2025 Feb 6:S2588-9311(25)00002-1. doi: 10.1016/j.euo.2025.01.002. Online ahead of print. Eur Urol Oncol. 2025. PMID: 39920014 Free PMC article.
Non-invasive recording from the human olfactory bulb.
Iravani B, Arshamian A, Ohla K, Wilson DA, Lundström JN. Iravani B, et al. Nat Commun. 2020 Jan 31;11(1):648. doi: 10.1038/s41467-020-14520-9. Nat Commun. 2020. PMID: 32005822 Free PMC article.
Black Phosphorus-based Photocatalysts: Synthesis, Properties, and Applications.
Moradian S, Badiei A, Mohammadi Ziarani G, Mohajer F, Varma RS, Iravani S. Moradian S, et al. Environ Res. 2023 Nov 15;237(Pt 1):116910. doi: 10.1016/j.envres.2023.116910. Epub 2023 Aug 18. Environ Res. 2023. PMID: 37597834 Review.
The techniques for improving the photocatalytic and stability of BP-based composites are discussed along with their multifaceted applications for environmental remediation, pollution degradation, water splitting, N(2) fixation, CO(2) reduction, bacterial disinfection, H(2) …
The techniques for improving the photocatalytic and stability of BP-based composites are discussed along with their multifaceted application …
Respiration Modulates Olfactory Memory Consolidation in Humans.
Arshamian A, Iravani B, Majid A, Lundström JN. Arshamian A, et al. J Neurosci. 2018 Nov 28;38(48):10286-10294. doi: 10.1523/JNEUROSCI.3360-17.2018. Epub 2018 Oct 22. J Neurosci. 2018. PMID: 30348674 Free PMC article.
In two separate sessions, female and male participants encoded odors followed by a 1 h awake resting consolidation phase where they either breathed solely through their nose or mouth. ...
In two separate sessions, female and male participants encoded odors followed by a 1 h awake resting consolidation phase where they e …
54 results